Bragina, O., von Witting, E., Garousi, J., Zelchan, R., Sandström, M., Orlova, A., Medvedeva, A., Doroshenko, A., Vorobyeva, A., Lindbo, S., Borin, J., Tarabanovskaya, N., Sörensen, J., Hober, S., Chernov, V., & Tolmachev, V. Phase I Study of 99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer //Journal of nuclear medicine. – 2021. – Vol. 62. – No. 4. – P. 493–499. DOI:10.2967/jnumed.120.248799 https://jnm.snmjournals.org/content/62/4/493
Bragina, O., Chernov, V., Schulga, A., Konovalova, E., Garbukov, E., Vorobyeva, A., Orlova, A., Tashireva, L., Sorensen, J., Zelchan, R., Medvedeva, A., Deyev, S., & Tolmachev, V. Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer //Journal of nuclear medicine: official publication, Society of Nuclear Medicine.– 2021. – jnumed.121.262542. Advance online publication. DOI:10.2967/jnumed.121.262542 https://jnm.snmjournals.org/content/early/2021/08/12/jnumed.121.262542
Oroujeni, M., Rinne, S.S., Vorobyeva, A., Loftenius, A., Feldwisch, J., Jonasson, P., Chernov, V., Orlova, A., Frejd, F.Y., Tolmachev, V. Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake //International Journal of Molecular Sciences. – 2021. – Vol. 22. – No. 2770. DOI:10.3390/ijms22052770 https://www.mdpi.com/1422-0067/22/5/2770
Abouzayed, A., Rinne, S. S., Sabahnoo, H., Sörensen, J., Chernov, V., Tolmachev, V., Orlova, A. Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer //Pharmaceutics. – 2021. – Vol. 13. – No. 2. – P. 182. DOI: 10.3390/pharmaceutics13020182 https://www.mdpi.com/1999-4923/13/2/182
Dudnikova Y.A., Chernov V.I., Muravleva A.V., Kravchuk T.L., Zelchan R.V., Medvedeva A.A., Bragina O.D., Simolina Y.L., Popova N.O., Vysockaja V.V., Lukina N.M., Shatalova V.A., Shpileva O.V., Goldberg A.V., Goldberg V.Y. Metabolic single-photon emission computed tomography with the new radiopharmceutical 99Tc-1-thio-D-glucose in the diagnosis and monitoring of the primary breast lymphoma (case report) //Siberian journal of oncology. – 2020. – Vol. 19. – No.5. – P. 145-153. DOI: 10.21294/1814-4861-2020-19-5-145-153 https://www.siboncoj.ru/jour/article/view/1589